Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Gold and Silver Stocks Dominate TSX30 List of...

September 10, 2025

LaFleur Minerals Files Amended and Restated Offering Document

August 20, 2025

Living Plants Offer New Path to Rare Earths...

November 18, 2025

Basin Energy

September 1, 2025

Finlay Minerals Ltd. engages Investing News Network

July 8, 2025

Purepoint Uranium Announces $3 Million Charity Flow-Through Private...

August 14, 2025

Biggest US Defense Contractors and ETFs in 2025

July 16, 2025

SAGA Metals Completes Maiden Drill Program and Commences...

April 17, 2025

Rob McEwen: Gold to Hit US$5,000 Long Term,...

March 18, 2025

Crypto Market Recap: Kraken Expands Services, EURC Momentum...

April 15, 2025